CA Patent

CA2772127A1 — Formulations for c-met kinase inhibitors

Assigned to Organon Pharma UK Ltd · Expires 2011-04-07 · 15y expired

What this patent protects

The instant invention relates to pharmaceutical compositions containing c-Met kinase inhibitors. Also disclosed are processes for making said pharmaceutical compositions.

USPTO Abstract

The instant invention relates to pharmaceutical compositions containing c-Met kinase inhibitors. Also disclosed are processes for making said pharmaceutical compositions.

Drugs covered by this patent

Patent Metadata

Patent number
CA2772127A1
Jurisdiction
CA
Classification
—
Expires
2011-04-07
Drug substance claim
No
Drug product claim
No
Assignee
Organon Pharma UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.